دورية أكاديمية

Therapeutic Response to Single-Inhaler Triple Therapies in Moderate-to-Severe COPD.

التفاصيل البيبلوغرافية
العنوان: Therapeutic Response to Single-Inhaler Triple Therapies in Moderate-to-Severe COPD.
المؤلفون: Kengo Ohtsuka, Naoko Harada, Atsuo Horiuchi, Shintaro Umemoto, Ryo Kurabatashi, Akie Yui, Hiroyuki Yamamura, Yoko Shinka, Naoki Miyao
المصدر: Respiratory Care; Mar2023, Vol. 68 Issue 3, p330-337, 8p
مصطلحات موضوعية: ADRENERGIC beta agonists, STATISTICS, COMBINATION drug therapy, CONFIDENCE intervals, ANALYSIS of variance, CONTINUING education units, MANN Whitney U Test, SEVERITY of illness index, TREATMENT effectiveness, COMPARATIVE studies, T-test (Statistics), OBSTRUCTIVE lung diseases, PULMONARY function tests, DESCRIPTIVE statistics, INHALATION administration, ODDS ratio, DATA analysis, DATA analysis software, SENSITIVITY & specificity (Statistics), MUSCARINIC antagonists, BECLOMETHASONE dipropionate
مصطلحات جغرافية: JAPAN
مستخلص: BACKGROUND: COPD is characterized by progressive and irreversible air flow limitations. Single-inhaler therapies (SITTs) incorporating an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting β2-agonist have been shown to effectively alleviate symptoms and improve lung function. Fluticasone-furoate/umeclidinium/vilanterol (F/U/V) and budesonide/glyco-pyrronium/formoterol (B/G/F) are available as SITT in Japan. However, the clinical differences between these 2 combinations and the predictors of their proper use have not been established. This study aimed to identify the subject characteristics that could predict the effectiveness of inhaler therapy. METHODS: We assessed the pulmonary function test results of subjects with COPD before and one month after using F/U/V and B/G/F as SITT. Subjects with a difference of 100 mL or more in the FEV1 after treatment with pre-SITT were extracted and divided into the F/U/V effect and no-effect group and B/G/F effect and no-effect group to examine the factors associated with positive outcomes with each inhaler. RESULTS: F/U/V and B/G/F significantly improved the inspiratory capacity (IC), %IC, FVC, and %FEV1 when compared to pre-inter-vention values (P < .001, P = .001, P = .007, P = .009, respectively, for F/U/V; and P = .006, P = .008, P = .038, P = .005, respectively, for B/G/F). Factors associated with FEV1 improvement in F/U/V included lower %IC (odds ratio 0.97 [95% CI 0.94-0.99], P = .03) and a higher modified Medical Research Council (mMRC) dyspnea score (2.36 [1.27-4.70], P < .01). In addition, a higher %IC (1.03 [1.00-1.06], P = .02) and lower mMRC dyspnea score (0.55 [0.28-0.99], P = .041) were predictors for the effectiveness of B/G/F. CONCLUSIONS: Our results showed that SITT significantly improved the IC, %IC, FVC, and %FEV1 when compared to pre-inter-vention and that F/U/V was more effective in subjects with severe symptoms, whereas B/G/F was more effective in subjects with mild symptoms. [ABSTRACT FROM AUTHOR]
Copyright of Respiratory Care is the property of American Association for Respiratory Care and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:00201324
DOI:10.4187/respcare.10188